Fair Value Measurements - Balance sheet (Details) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Fair value, balance sheet
Cash and cash equivalents	$ 8,129	$ 7,021
Available-For-Sale (Current)	49,938	64,332
Available-For-Sale (Non-Current)	1,001
Estimated Fair Value	56,261	67,098
Commercial paper
Fair value, balance sheet
Estimated Fair Value	1,988	10,387
Corporate notes / bonds
Fair value, balance sheet
Estimated Fair Value	35,558	45,826
U.S. treasuries
Fair value, balance sheet
Estimated Fair Value	9,262	6,649
U.S. govt. agencies
Fair value, balance sheet
Estimated Fair Value	4,131	1,470
Money market funds
Fair value, balance sheet
Estimated Fair Value	5,322	2,766
Recurring
Fair value, balance sheet
Cash and cash equivalents	5,322	2,766
Available-For-Sale (Current)	49,938	64,332
Available-For-Sale (Non-Current)	1,001
Estimated Fair Value	56,261	67,098
Recurring \| Commercial paper
Fair value, balance sheet
Available-For-Sale (Current)	1,988	10,387
Estimated Fair Value	1,988	10,387
Recurring \| Corporate notes / bonds
Fair value, balance sheet
Available-For-Sale (Current)	35,558	45,826
Estimated Fair Value	35,558	45,826
Recurring \| U.S. treasuries
Fair value, balance sheet
Available-For-Sale (Current)	8,261	6,649
Available-For-Sale (Non-Current)	1,001
Estimated Fair Value	9,262	6,649
Recurring \| U.S. govt. agencies
Fair value, balance sheet
Available-For-Sale (Current)	4,131	1,470
Estimated Fair Value	4,131	1,470
Recurring \| Money market funds
Fair value, balance sheet
Cash and cash equivalents	5,322	2,766
Estimated Fair Value	$ 5,322	$ 2,766

Zomedica Corp. 10-Q